Relighting Cigarettes for Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how relighting cigarettes affects the levels of harmful chemicals in smoke and smokers' experiences. Participants will compare smoking a cigarette continuously with relighting it later. The study aims to determine if relighting increases exposure to toxic chemicals. Suitable participants have smoked at least 10 cigarettes a day for a year and relight at least half of their cigarettes. The trial is not suitable for those planning to quit smoking soon.
As an unphased trial, this study offers smokers a chance to contribute to important research on smoking habits and chemical exposure.
Do I have to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on smoking behaviors rather than medication use.
What prior data suggests that relighting cigarettes is safe?
Research shows that relighting cigarettes can harm health. Studies have found that relighting increases the risk of lung cancer and chronic bronchitis. Relighting may release more harmful chemicals than smoking a cigarette continuously.
These findings suggest that relighting poses greater danger than smoking a cigarette without interruption. While the current trial aims to better understand these effects, existing research highlights potential safety concerns for those who frequently relight cigarettes.12345Why are researchers excited about this trial?
Researchers are intrigued by the idea of relighting cigarettes because it challenges our understanding of smoking patterns and its effects on health. Unlike traditional continuous smoking, relighting could alter exposure to harmful substances since cigarettes burn differently when relit. This trial aims to uncover if relighting could potentially change the risk profile associated with smoking, providing valuable insights into smoking behaviors and their health impacts. By comparing continuous smoking with relight smoking, scientists hope to gather data that could inform future smoking cessation strategies or public health guidelines.
What evidence suggests that relighting cigarettes affects smoke toxicant levels and smoking behavior?
Research has shown that relighting cigarettes increases the harmful chemicals in the smoke. Studies found that relit cigarettes release more toxic substances than those smoked continuously. In this trial, participants will be assigned to either a continuous smoking condition or a relight smoking condition to compare the effects. Approximately 45% of smokers relight their cigarettes, often due to higher nicotine addiction. Some smokers believe relighting helps them smoke less, but it is not necessarily safer. Evidence suggests that relighting leads to more intense exposure to harmful chemicals.26789
Are You a Good Fit for This Trial?
This trial is for smokers who have smoked at least 10 cigarettes a day for over a year, regularly relight their cigarettes, and aren't trying to quit soon. They should be medically stable with specific blood pressure and heart rate limits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in smoking sessions with relit and non-relit cigarettes, with measurements taken before and after smoking.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Relighting
Trial Overview
The study investigates the effects of relighting cigarettes on smoke toxicant levels and smoker's experiences. It involves comparing toxicants from usual cigarettes when smoked normally versus being relit in both natural settings and clinic measurements.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
During the study visits, measures will be taken before and after participants smoke their own usual brand cigarette one continuously. Participants will be randomly assigned to continuous smoking or relight smoking conditions. Participants randomized to the relight smoking condition will crossover to the continuous smoking condition after 60 minutes on their first visit. Visits will be separated by 7-10 days, to ensure there are 2 weekdays and 1 weekend day falling in that period for cigarette butt collection. On the second visit, participants will begin with the second smoking condition they were assigned on their first visit. They will crossover to the remaining condition after 60 minutes. Participants initially assigned to the relighting smoking condition will begin their second visit with the continuous smoking condition and cross over to the relighting smoking condition after the 60 minutes.
During the study visits, measures will be taken before and after participants smoke their own usual brand cigarette one continuously. Participants will be randomly assigned to continuous smoking or relight smoking conditions. Participants randomized to the continuous smoking condition will crossover to the relight smoking condition after 60 minutes on their first visit. Visits will be separated by 7-10 days, to ensure there are 2 weekdays and 1 weekend day falling in that period for cigarette butt collection. On the second visit, participants will begin with the second smoking condition they were assigned on their first visit. They will crossover to the remaining condition after 60 minutes. Participants initially assigned to the continuous smoking condition will begin their second visit with the relighting smoking condition and cross over to the continuous smoking condition after the 60 minutes.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Masonic Cancer Center, University of Minnesota
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator
Published Research Related to This Trial
Citations
The Impact of Cigarette Relighting on Nicotine ...
Of the 31 participants who reported a >=50% reduction in CPD at 3-month follow-up, 5 (16%) did not achieve the outcome of >=50% reduction in the frequency of ...
Measurement of cigarette relighting: A common but ...
Similarly, 59% reported relighting to make cigarettes last longer. Nearly half (44%) reported relighting to cut down or quit smoking, and 34% do ...
Relighting behaviour among cigarette smokers seeking ...
Results. Forty-six per cent of the sample reported relighting, and those subjects smoked significantly fewer cigarettes per day (CPD), despite ...
4.
researchgate.net
researchgate.net/publication/352469281_Cigarette_Relighting_A_Series_of_Pilot_Studies_Investigating_a_Common_Yet_Understudied_Smoking_BehaviorCigarette Relighting: A Series of Pilot Studies Investigating ...
Relighting was found to be common (approximately 45% of smokers), and associated with lower socioeconomic status, heavier smoking and nicotine dependence.
Effects of Relighting on Smoke Toxicant Deliveries and ...
Hypothesis: Relit cigarettes will produce higher levels of toxicants than non-relit cigarettes. Official Title. Effects of Relighting on Smoke Toxicant ...
Characteristics of Adult Cigarette Smokers Who “Relight” ...
The authors suggested that relighting cigarettes significantly contributed to lung cancer risk. This study was conducted during a period of time when most ...
Cigarette Relighting Tied to Tough Economy
“In fact, smokers who relight cigarettes may be at higher risk of lung cancer and chronic bronchitis. That is something of which policy makers need to be aware, ...
Alkaloids and nitrosamines in tobacco filler of half-smoked ...
Moreover, relighting cigarettes is associated with increased lung cancer risk and higher rates of chronic bronchitis.
Cigarette Relighting: A Series of Pilot Studies Investigating ...
In 2016, daily smokers who frequently thought about smoking health risks had a higher prevalence of frequent relighting (23%) than those who ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.